1. Sanggenon C Suppresses Tumorigenesis of Gastric Cancer by Blocking ERK-Drp1-Mediated Mitochondrial Fission
- Author
-
Xiao-jie Chen, Qi-xiao Cui, Guo-li Wang, Xiao-li Li, Xiao-lin Zhou, Hui-jie Zhao, Ming-qian Zhang, Min-jing Li, Xiao-juan He, Qiu-sheng Zheng, Yu-liang Wang, Defang Li, and Pan Hong
- Subjects
Pharmacology ,Carcinogenesis ,Organic Chemistry ,Mice, Nude ,Pharmaceutical Science ,Apoptosis ,Mitochondrial Dynamics ,Analytical Chemistry ,Mice ,Complementary and alternative medicine ,Stomach Neoplasms ,Cell Line, Tumor ,Drug Discovery ,Animals ,Humans ,Molecular Medicine ,Protein Kinases ,Cell Proliferation - Abstract
Sanggenon C is a flavonoid extracted from the root bark of white mulberry, which is a traditional Chinese medicine with anti-inflammatory, antioxidative, and antitumor pharmacological effects. In this study, sanggenon C was found to inhibit human gastric cancer (GC) cell proliferation and colony formation, induce GC cell cycle arrest in the G0-G1 phase, and promote GC cell apoptosis. Moreover, sanggenon C was found to decrease the level of mitochondrial membrane potential in GC cells and inhibit mitochondrial fission. Mechanistically, RNA sequencing, bioinformatics analysis, and a series of functional analyses confirmed that sanggenon C inhibited mitochondrial fission to induce apoptosis by blocking the extracellular regulated protein kinases (ERK) signaling pathway, and constitutive activation of ERK significantly abrogated these effects. Finally, sanggenon C was found to suppress the growth of tumor xenografts in nude mice without obvious side effects to the vital organs of animals. This study reveals that sanggenon C could be a novel therapeutic strategy for GC treatment.
- Published
- 2022
- Full Text
- View/download PDF